Literature DB >> 22207591

Altered lymphatics in an ovine model of congenital heart disease with increased pulmonary blood flow.

Sanjeev A Datar1, Eric G Johnson, Peter E Oishi, Michael Johengen, Eric Tang, Angela Aramburo, Jubilee Barton, Hsuan-Chang Kuo, Stephen Bennett, Konstantine Xoinis, Bhupinder Reel, Gokhan Kalkan, Eniko Sajti, Oscar Osorio, Gary W Raff, Michael A Matthay, Jeffrey R Fineman.   

Abstract

Abnormalities of the lymphatic circulation are well recognized in patients with congenital heart defects. However, it is not known how the associated abnormal blood flow patterns, such as increased pulmonary blood flow (PBF), might affect pulmonary lymphatic function and structure. Using well-established ovine models of acute and chronic increases in PBF, we cannulated the efferent lymphatic duct of the caudal mediastinal node and collected and analyzed lymph effluent from the lungs of lambs with acutely increased PBF (n = 6), chronically increased PBF (n = 6), and age-matched normal lambs (n = 8). When normalized to PBF, we found that lymph flow was unchanged following acute increases in PBF but decreased following chronic increases in PBF. The lymph:plasma protein ratio decreased with both acute and chronic increases in PBF. Lymph bioavailable nitric oxide increased following acute increases in PBF but decreased following chronic increases in PBF. In addition, we found perturbations in the transit kinetics of contrast material through the pleural lymphatics of lambs with chronic increases in PBF. Finally, there were structural changes in the pulmonary lymphatic system in lambs with chronic increases in PBF: lymphatics from these lambs were larger and more dilated, and there were alterations in the expression of vascular endothelial growth factor-C, lymphatic vessel endothelial hyaluronan receptor-1, and Angiopoietin-2, proteins known to be important for lymphatic growth, development, and remodeling. Taken together these data suggest that chronic increases in PBF lead to both functional and structural aberrations of lung lymphatics. These findings have important therapeutic implications that warrant further study.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22207591      PMCID: PMC3311527          DOI: 10.1152/ajplung.00324.2011

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  67 in total

1.  Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1.

Authors:  Nicholas W Gale; Gavin Thurston; Sean F Hackett; Roumiana Renard; Quan Wang; Joyce McClain; Cliff Martin; Charles Witte; Marlys H Witte; David Jackson; Chitra Suri; Peter A Campochiaro; Stanley J Wiegand; George D Yancopoulos
Journal:  Dev Cell       Date:  2002-09       Impact factor: 12.270

2.  Inhaled nitric oxide-induced rebound pulmonary hypertension: role for endothelin-1.

Authors:  D M McMullan; J M Bekker; M J Johengen; K Hendricks-Munoz; R Gerrets; S M Black; J R Fineman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-02       Impact factor: 4.733

3.  The influence of a restrictive atrial septal defect on pulmonary vascular morphology in patients with hypoplastic left heart syndrome.

Authors:  J N Graziano; K P Heidelberger; G J Ensing; C A Gomez; A Ludomirsky
Journal:  Pediatr Cardiol       Date:  2002-02-19       Impact factor: 1.655

4.  Inhibition of the active lymph pump by flow in rat mesenteric lymphatics and thoracic duct.

Authors:  Anatoliy A Gashev; Michael J Davis; David C Zawieja
Journal:  J Physiol       Date:  2002-05-01       Impact factor: 5.182

5.  Role for endothelin-1-induced superoxide and peroxynitrite production in rebound pulmonary hypertension associated with inhaled nitric oxide therapy.

Authors:  S Wedgwood; D M McMullan; J M Bekker; J R Fineman; S M Black
Journal:  Circ Res       Date:  2001-08-17       Impact factor: 17.367

6.  Alterations in nitric oxide production in 8-week-old lambs with increased pulmonary blood flow.

Authors:  Stephen M Black; Janine M Bekker; D Michael McMullan; Andrew J Parry; Boaz Ovadia; Olaf Reinhartz; Satyan Lakshminrushimha; Eugenia Mata-Greenwood; Robin H Steinhorn; Jeffrey R Fineman
Journal:  Pediatr Res       Date:  2002-08       Impact factor: 3.756

Review 7.  Research perspectives in inherited lymphatic disease.

Authors:  Robert E Ferrell
Journal:  Ann N Y Acad Sci       Date:  2002-12       Impact factor: 5.691

8.  Therapeutic lymphangiogenesis with human recombinant VEGF-C.

Authors:  Andrzej Szuba; Mihaela Skobe; Marika J Karkkainen; William S Shin; David P Beynet; Ned B Rockson; Noma Dakhil; Stan Spilman; Michael L Goris; H William Strauss; Thomas Quertermous; Kari Alitalo; Stanley G Rockson
Journal:  FASEB J       Date:  2002-10-18       Impact factor: 5.191

9.  Alterations in ET-1, not nitric oxide, in 1-week-old lambs with increased pulmonary blood flow.

Authors:  Boaz Ovadia; Olaf Reinhartz; Robert Fitzgerald; Janine M Bekker; Michael J Johengen; Anthony Azakie; Stephan Thelitz; Stephen M Black; Jeffrey R Fineman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-10-24       Impact factor: 4.733

10.  Lymphangiogenic gene therapy with minimal blood vascular side effects.

Authors:  Anne Saaristo; Tanja Veikkola; Tuomas Tammela; Berndt Enholm; Marika J Karkkainen; Katri Pajusola; Hansruedi Bueler; Seppo Ylä-Herttuala; Kari Alitalo
Journal:  J Exp Med       Date:  2002-09-16       Impact factor: 14.307

View more
  9 in total

1.  Vascular endothelial growth factor receptor 3 signaling contributes to angioobliterative pulmonary hypertension.

Authors:  Ayser Al-Husseini; Donatas Kraskauskas; Eleanora Mezzaroma; Andrea Nordio; Daniela Farkas; Jennifer I Drake; Antonio Abbate; Quentin Felty; Norbert F Voelkel
Journal:  Pulm Circ       Date:  2015-03       Impact factor: 3.017

2.  Altered reactivity and nitric oxide signaling in the isolated thoracic duct from an ovine model of congenital heart disease with increased pulmonary blood flow.

Authors:  Sanjeev A Datar; Peter E Oishi; Wenhui Gong; Stephen H Bennett; Christine E Sun; Michael Johengen; Jun Maki; Rebecca C Johnson; Gary W Raff; Jeffrey R Fineman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-02-14       Impact factor: 4.733

Review 3.  Lymphatic dysfunction in critical illness.

Authors:  Edmund Burke; Sanjeev A Datar
Journal:  Curr Opin Pediatr       Date:  2018-06       Impact factor: 2.856

Review 4.  Imaging of fetal lymphangiectasias: prenatal and postnatal imaging findings.

Authors:  Christian A Barrera; Teresa Victoria; Fernando A Escobar; Ganesh Krishnamurthy; Christopher L Smith; Julie S Moldenhauer; David M Biko
Journal:  Pediatr Radiol       Date:  2020-11-30

5.  Disrupted NOS signaling in lymphatic endothelial cells exposed to chronically increased pulmonary lymph flow.

Authors:  Sanjeev A Datar; Wenhui Gong; Youping He; Michael Johengen; Rebecca J Kameny; Gary W Raff; Emin Maltepe; Peter E Oishi; Jeffrey R Fineman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-05-13       Impact factor: 4.733

6.  KLF2-mediated disruption of PPAR-γ signaling in lymphatic endothelial cells exposed to chronically increased pulmonary lymph flow.

Authors:  Catherine J Morris; Rebecca J Kameny; Jason Boehme; Wenhui Gong; Youping He; Terry Zhu; Emin Maltepe; Gary W Raff; Jeffrey R Fineman; Sanjeev A Datar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-04-06       Impact factor: 4.733

7.  Preliminary evidence that hydrostatic edema may contribute to the formation of diffuse alveolar damage in a Holstein calf model.

Authors:  Joseph M Neary; Dee Church
Journal:  F1000Res       Date:  2018-03-26

8.  HIF-1α promotes cellular growth in lymphatic endothelial cells exposed to chronically elevated pulmonary lymph flow.

Authors:  Jason T Boehme; Catherine J Morris; Samuel R Chiacchia; Wenhui Gong; Katherine Y Wu; Rebecca J Kameny; Gary W Raff; Jeffrey R Fineman; Emin Maltepe; Sanjeev A Datar
Journal:  Sci Rep       Date:  2021-01-14       Impact factor: 4.379

9.  Lymphatic Endothelial Cell Defects in Congenital Cardiac Patients With Postoperative Chylothorax.

Authors:  Aqsa Shakoor; June K Wu; Ajit Muley; Christopher Kitajewski; Joseph D McCarron; Noa Shapiro-Franklin; Rozelle Corda; Sophia Chrisomalis-Dring; Paul J Chai; Carrie J Shawber
Journal:  J Vasc Anom (Phila)       Date:  2021-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.